Dr. Temple contributed to a recent article on a stem cell clinical trial that has recently received the Food and Drug Administration’s new Regenerative Medicine Advanced Therapy (RMAT) designation.
Read more about how this new designation will help to promote the advancement of legitimate stem cell therapies: https://www.the-scientist.com/?articles.view/articleNo/51539/title/Trends-in-Synthetic-Biology–Antibody-Engineering/
Leave a Reply